CAS: 103898-11-9; Tert-Butyl Bis(2-Hydroxyethyl)Carbamate

该化合物是二乙醇胺的一种受保护衍生物,其特点是一个增强合成化学稳定性和效用的乙型丁氧碳基(Boc)组,该组在丙二醇合成和有机转化中特别有用,该组作为氨的暂时保护组,在温和条件下能够有选择地作出反应,其双功能结构,结合了氢氧基和受生物保护的安咪类,允许在准备复杂的分子,药品和聚合物时采用多种用途.Boc组可以在酸性条件下随时去除,提供受控制的去保护,同时又不干扰敏感的功能组.这使得N-Boc-二乙醇胺成为多步骤合成途径的可靠中间体.

结构式图片

欧盟法规

ECHA物质C&L通报

上下游产品

CAS号24424-99-5 二碳酸二叔丁酯 | CAS号111-42-2 二乙醇胺 | CAS号41840-28-2 S-B°C-2-巯基-4,6-二甲基嘧啶 | CAS号401518-12-5 1-B°C-4-氰基-4-[3... | CAS号401518-11-4 N-B°C-N,N-双{2-[...

合成工艺路线路线简述

    二碳酸二叔丁酯,二乙醇胺置于三乙胺体系中,用 二氯甲烷 用作溶剂,化学反应生成N-叔丁氧羰基二乙胺
    参考文献:用于dna传递的基于cyclenn的双尾脂质:合成及其连接基团结构的影响
    标题:用于dna传递的基于cyclenn的双尾脂质:合成及其连接基团结构的影响
    摘要:阳离子脂质的基因转染效率(te)在很大程度上受脂质结构的影响.六种新颖的1,4,7,10-四氮杂十二烷基(环素)基阳离子脂质l1-L6设计并合成了含有双油基作为疏水尾基的化合物.这些脂质之间的区别是它们的不同骨架.由脂质和dope制备的脂质体显示出非常好的dna亲和力,并且可以在n / P为4时实现完全的dna缩合,形成具有适当大小和zeta电位的脂质复合体,用于基因转染.研究了这些脂质作为非病毒基因传递载体的构效关系.研究发现,较小的骨架结构变化(包括连接基团和结构对称性)会影响te.二亚乙基三胺衍生的脂质l4含有酰胺连接键的te效果最好,比市售转染试剂lipofectamine 2000高出几倍.此外,这些脂质显示出低细胞毒性,表明它们具有非常好的生物相容性.结果表明,这种类型的阳离子脂质可能是有前途的非病毒基因载体,也为设计具有更高te和生物相容性的新型载体提供了线索.
    Doi:10.1016/j.Bmc.2015.07.005

    海关参考信息

    专利信息


    专利号:US-2004110228-A1
    优先权日:2002-04-01
    标 题:Combinatorial organic synthesis of unique biologically active compounds
    发明人:MCALPINE SHELLI R; TAYLOR RACHEL E; BOLLA MEGAN L; SEGALL ANCA M
    摘要:The invention provides a method for making a combinatorial library of cyclic compounds, such as Holliday junction-trapping compounds, comprising the steps of (a) obtaining a plurality of trimers according to the generic structure X 1- X 2- X 3 , wherein X 1 , X 2 and X 3 can be independently any naturally or nonnaturally occurring amino acids or peptidomimetics thereof; (b) optionally coupling a spacer S to the trimer at either end; (c) cyclizing two trimers or trimer-spacer conjugates in a head-to-tail orientation; thereby obtaining a combinatorial library of compounds, wherein the library does not include an unmodifed or naturally occurring Holliday Junction-trapping compounds. The invention additionally provides methods macrocyclic compounds that are synergimycin derivatives.

    专利号:US-2024299311-A1
    优先权日:2022-04-05
    标题 :Ionizable cationic lipids and lipid nanoparticles
    发明人:KARMALI PRIYA PRAKASH; TANIS STEVEN
    权利人:KARMALI PRIYA PRAKASH; TANIS STEVEN; CAPSTAN THERAPEUTICS INC
    摘要:Ionizable cationic lipids, methods for synthesizing them, as well as intermediates useful in synthesis of these lipids and methods of synthesizing the intermediates are disclosed. The ionizable cationic lipids are useful as a component of lipid nanoparticles (LNP), which in turn can be used for the delivery of nucleic acids into cells in vivo or ex vivo. LNP compositions are also disclosed, including LNP comprising a functionalized lipid to enable conjugation of a binding moiety, and targeted LNP (tLNP), that is a LNP in which a binding moiety has been conjugated to the functionalized lipid and can serve as a targeting moiety to direct the tLNP to a desired tissue or cell type.

    专利号:US-2023250056-A1
    优先权日:2020-06-24
    标 题 :Process for synthesizing lipids
    发明人:BEUTNER GREGORY LOUIS; LORA GONZALEZ FEDERICO; CHO PATRICIA Y; SMITH MICHAEL J
    权利人:BRISTOL MYERS SQUIBB CO
    摘要:The present application provides processes for synthesizing lipids of Formula I useful in the synthesis of fat-soluble compounds for targeting and enhancing activity of therapeutic molecules, including siRNA.

    专利号:US-2023265050-A1
    优先权日:2020-06-24
    标 题 :Process for synthesizing cationic lipids
    发明人:BEUTNER GREGORY LOUIS; CARRASQUILLO-FLORES RONALD; LORA GONZALEZ FEDERICO; SMITH MICHAEL J
    权利人:BRISTOL MYERS SQUIBB CO
    摘要:The present application provides processes for synthesizing cationic lipids of Formula I useful in the synthesis of fat-soluble compositions for targeting and enhancing activity of therapeutic molecules, including siRNA.

    专利号:US-8043786-B2
    优先权日:2003-03-05
    标题 :Acid generators, sulfonic acids, sulfonyl halides, and radiation sensitive resin compositions
    发明人:EBATA SATOSHI; WANG YONG; NISHIMURA ISAO
    权利人:JSR CORP
    摘要:The invention provides novel acid generators which are unproblematic in combustibility and accumulation inside the human body and can generate acids having high acidities and high boiling points and exhibiting properly short diffusion lengths in resist coating films and which permit the formation of resist patterns excellent smoothness with little dependence on the denseness of a mask pattern; sulfonic acids generated from the acid generators; sulfonyl halides useful as raw material in the synthesis of the acid generators; and radiation-sensitive resin compositions containing the acid generators. The acid generators have structures represented by the general formula (I), n nwherein R 1 is a monovalent substituent such as alkoxycarbonyl, alkylsulfonyl, or alkoxysulfonyl; R 2 to R 4 are each hydrogen or alkyl; k is an integer of 0 or above; and n is an integer of 0 to 5. Among the radiation-sensitive resin compositions, a positive one contains a resin having acid-dissociable groups in addition to the above acid generator, while a negative one contains an alkali-soluble resin and a crosslinking agent in addition to the acid generator.

    专利号:WO-2025076113-A1
    优先权日:2023-10-05
    标题:Ionizable cationic lipids with conserved spacing and lipid nanoparticles
    发明人:KARMALI PRIYA PRAKASH; TANIS STEVEN; BAO YANJIE
    权利人:CAPSTAN THERAPEUTICS INC
    摘要:Ionizable cationic lipids, methods for synthesizing the same, intermediates useful in synthesis of the ionizable cationic lipids, and methods of synthesizing the intermediates are disclosed. The ionizable cationic lipids are useful as a component of lipid nanoparticles (LNP), which in turn can be used for delivering nucleic acids into cells in vivo or ex vivo. LNP compositions are also disclosed, including LNP comprising a functionalized lipid to enable conjugation of a binding moiety, and targeted LNP (tLNP), that is a LNP in which a binding moiety has been conjugated to the functionalized lipid and can serve as a targeting moiety to direct the tLNP to a desired tissue or cell type.
    杭州法玛化学品有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.hzph.com
    企业联系电话:0571-87040515👤
    📞杭州法玛化学品有限公司 ⚠️参考联系方式

    电话:0571-87040515

    传真:0571-87214761
    邮箱:chenhk@hzph.com
    通信地址: 上城区庆联大厦1201室
    邮编: 310003
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:上城区庆联大厦1201室
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献


    1: Brown A, Patel S, Ward C, Lorenz A, Ortiz M, DuRoss A, Wieghardt F, Esch A, Otten EG, Heiser LM, Korolchuk VI, Sun C, Sarkar S, Sahay G. PEG-lipid micelles enable cholesterol efflux in Niemann-Pick Type C1 disease-based lysosomal storage disorder. Sci Rep. 2016 Aug 30;6:31750. doi: 10.1038/srep31750.
    2: Saifer MG, Williams LD, Sobczyk MA, Michaels SJ, Sherman MR. Selectivity of binding of PEGs and PEG-like oligomers to anti-PEG antibodies induced by methoxyPEG-proteins. Mol Immunol. 2014 Feb;57(2):236-46. doi: 10.1016/j.molimm.2013.07.014. Epub 2013 Nov 5. doi: 10.1517/17425247.2012.720969. Epub 2012 Aug 30.

    合成参考文献


    摘要:Sasano, Y.; Iwabuchi, Y., Science of Synthesis: Special Topics, (2022) 1, 338.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知